Recombinant human insulin biosimilar (Akston)

重组人胰岛素生物类似药（Akston）

Report date: 2024/04/08 16:37:36

Base Information

Drug NameRecombinant human insulin biosimilar (Akston)
Drug Alias NameHuman Weekly Insulin (Akston)FcRn recycled insulin for once-a-week dosing (Akston)AKS-440
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkston Biosciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAkston Biosciences Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A